Germany's Evonik Q2 revenue up 11% on higher volumes and prices
Germany's Evonik Q2 revenue up 11% on higher volumes and prices
Overview
Germany chemical firm's Q2 adjusted EBITDA rose 24% to €630 mln on higher volumes and prices
Q2 revenue increased 11% yr/yr, while net income declined from prior-year quarter
Company extended efficiency program, targeting further job reductions and raised 2026 EBITDA outlook
Outlook
Evonik raises 2026 adjusted EBITDA guidance to €2.0 bln-€2.2 bln from €1.7 bln-€2.0 bln
Company continues to target a 2026 cash conversion rate of around 40%
Evonik says supply chain bottlenecks outside Europe are currently supporting earnings
Result Drivers
SUPPLY CHAIN BOTTLENECKS - Co said supply chain disruptions outside Europe, mainly due to Middle East conflict, led to higher volumes and prices
ADVANCED TECHNOLOGIES SEGMENT - Segment benefited from supply bottlenecks affecting Asian competitors, boosting sales and prices
ANIMAL NUTRITION BUSINESS - Higher volumes and improved prices for essential amino acids, mainly related to supply shortages in the Strait of Hormuz
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Adjusted EBITDA |
| EUR 630 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 7 "hold" and 4 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy."
Wall Street's median 12-month price target for Evonik Industries AG is €18.50, about 5.2% above its August 3 closing price of €17.59
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
Aug 4 - Evonik tops Q2 earnings estimates as Middle East conflict boosts demand
Aug 3 - Germany's Verbio prelim FY EBITDA tops guidance on higher selling prices
Aug 3 - Beiersdorf says Middle East conflict disrupts Gulf sales, deliveries
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Evonik Industries AG
See all newsEuropean industry calls for changes to carbon reform to avoid more factory closures
Europe chemicals downturn likely to spur more mergers, Lanxess CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
Brief: Evonik Invests €52 Mln To Expand Silicone Platform In Essen